Clinic
Zaki Badawy, MD PC
Zaki Badawy, MD PC was paid $379K by Medicaid between Oct 2023 and Dec 2024, across 13 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 35% of everything it billed.
33Billing provider infoZAKI BADAWY, MD PC
LIVERPOOL, NY 13090
LIVERPOOL, NY 13090
33aNPI1871206474assigned 12/29/2022
33bProvider typeUrgent Care Clinic/Center
28Total paid$379K
24GClaims8,377
24DCodes billed13
24AFirst – last monthOct 2023 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in New York
Rank by total paid#74 of 138
Median peer was paid$576K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 893 | $40K | |
| 2024incomplete | 7,484 | $339K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 35% | 1,784 | 1,784 | $131K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 1,192 | 1,164 | $71K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 17% | 770 | 756 | $64K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14% | 464 | 464 | $53K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.6% | 331 | 328 | $29K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.9% | 772 | 771 | $15K |
| 99051 | 2.7% | 2,467 | 2,436 | $10K | |
| 90713 | 1.1% | 93 | 93 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 99 | 99 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 85 | 83 | $701.49 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 236 | 233 | $290.96 |
| 81003 | <1% | 28 | 28 | $46.36 |
1 more codes
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 56 | $2.72 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPRINGER, LORI (EXECUTIVE ASSISTANT)